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Introduction to ADHD
Attention deficit hyperactivity disorder (ADHD) is a disorder 
most commonly seen in children and adolescents, but also may 
present or persist into adulthood. It is a neurocognitive behav-
ioral disorder that presents with symptoms of maladaptive be-
haviors such as impulsivity and or hyperactivity, the inability to 
pay attention and remain on task. ADHD is also associated with 
other maladies such as, mood disorders and learning disabilities 
(Journal of Attention Disorders, 2014). ADHD is costly because 
it is usually diagnosed in childhood and may become a lifelong 
disorder that causes a wide range of symptoms. In addition, chil-
dren with ADHD have been shown to be more likely to sustain 
major injuries and need both inpatient and outpatient emergen-
cy care. Median medical costs for children with ADHD were 
double those of children without the disorder when studied 
over a nine year period. 
Because of its prevalence amongst American children and 
adults and its high cost to the health care system, treatment 
of ADHD is important. Today, many treatments are available, 
these may include, behavioral as well as pharmaceutical ther-
apies. Medications available range from non-stimulant options 
to stimulants available in both extended release, long acting or 
traditional dosages (Journal of Attention Disorders, 2014). This 
paper will attempt to understand the causes of ADHD on a 
neurological level and evaluate possible treatment options, ana-
lyzing how physicians may be better able to match treatment to 
a patient lifestyle and disease. 
What is ADHD?
ADHD, attention deficit hyperactivity disorder, is a neurobiolog-
ical developmental disorder that is characterized by the inability 
to remain on task, difficulty to remain focused and the tendency 
to be overly energetic with impulsive behaviors. It is most com-
monly found in school-age children but can frequently continue 
into adulthood. ADHD is a widespread disease, having been 
found in all countries surveyed with a prevalence of about 7-8% 
of youths and 4-5% of adults. Furthermore, interestingly enough, 
ethnicity did not seem to be a factor in the frequency, however, 
social groups, were found to be most likely to play a role in the 
diagnosis (Journal of Attention Disorders, 2014). 
ADHD, attention deficit hyperactivity disorder, is broken up 
into three different categories, ADHD-I; ADHD, Predominantly 
Hyperactive-Impulsive Type; and ADHD, Combined Type: 
Inattentive and hyperactive/impulsive. ADD, attention deficit 
disorder, is an alternate name for ADHD-I, the first type of 
ADHD. ADHD is the broad term for the hyperactive, inattentive 
disease and ADD is a classification of ADHD. Firstly, ADHD-I, 
also known as ADD or ADHD-Inattentiveness, is diagnosed by 
the inability to keep on task or follow and understand instruc-
tions. Furthermore, children with ADD tend to make careless 
mistakes and use minimal effort in accomplishing difficult tasks. 
Additionally, the ADHD Predominantly Hyperactive-Impulsive 
Type is categorized by the individual suffering with the symp-
toms of hyperactivity, such as, fidgeting, squirming, trouble 
playing quietly or interrupting constantly. Lastly, the combined 
type of ADHD is characterized by a pattern of inattentiveness 
and over activity. Meaning, an individual with the combined type 
of ADHD will exhibit symptoms of fidgetiness, and inability to 
concentrate and remain seated, in addition to, signs of constant 
distraction and failure to remain on task (diffen.com). 
Causes of ADHD
Attention deficit hyperactive disorder can be triggered by many 
matters.  For instance, ADHD is mainly prompted by genetics, but, 
it can also be the result of the environment or specific brain inju-
ries. Firstly, many studies have proven hereditability to be the most 
common cause of ADHD. Genes can have the greatest impact on 
one’s children, whether it means passing down an advantageous 
trait, or passing down a disease, such as ADHD (myadhd.com). 
Family studies were performed in order to find the relationship 
between ADHD and genetics. Results have shown that 25% of 
closely-related family members with ADHD also have the disease. 
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Furthermore, adoption studies and twin studies were done in 
order to support the idea that ADHD is genetically related. If 
ADHD was not genetic, then adopted children should further 
resemble their adopted parents than their biological. However, 
reports have shown that adopted children are more similar to 
their biological parents, further supporting the point.  Twin stud-
ies, have shown similar results. Identical twins contain the same 
genetic materials as each other, and therefore, if one twin has the 
disease, the other twin does as well.  The last study that was done 
on ADHD patients, was molecular genetic research. Molecular 
genetic research focuses on the specific genes related to the 
transmission of ADHD. DAT1 and DRD4 are two dopamine 
genes that were discovered to have the biggest effect on ADHD 
gene transmission (myadhd.com).
Additionally, exposure to toxicity can be another cause of 
ADHD.  A relationship has been found between mothers who 
have smoked tobacco or intoxicated in alcohol during preg-
nancy, and the probability that learning disabilities and ADHD 
will develop in their child. Furthermore, lead exposure or poi-
soning in early years of childhood can have negative effects on 
the child’s progress and advancement.  The last, atypical, cause 
of ADHD can be a head or brain injury. Although somewhat 
unlikely, tumors, traumas, strokes or diseases can also result in 
ADHD as well (myadhd.com). 
ADHD and the Science of the Brain
Current research has proven that the causes of ADHD are high-
ly related to many dysfunctions of neurotransmitters and of re-
gions in the brain. A highly essential neurotransmitter, dopamine, 
has proven to have an effect in ADHD, as well as, the prefrontal 
cortex which requires high amounts of dopamine in order to 
function. Dopamine is a significant inhibiting neurotransmitter; 
meaning, that it plays a major role in preventing certain impuls-
es in the brain, and ultimately, preventing the causes of ADHD 
(dnalc.org). Dopamine transporters are found to be responsible 
for the lack of dopamine in the brain since they absorb too 
much dopamine, disabling it to transfer from one brain cell to 
another, thereby causing a dopamine deficiency in the brain. 
The basal ganglia, a collection of nuclei located throughout the 
brain, also suffer from the lack of dopamine, DA, present in the 
brain. The basal ganglia are responsible for motion or normal 
voluntary movement and are excited by dopamine transmitters. 
Therefore, a lack of dopamine also effects the role of the basal 
ganglia, causing ADHD. When the levels of dopamine are low, 
there are high risks for attention deficit hyperactivity disorder 
because the main neurotransmitter which inhibits impulses is 
lacking (dnalc.org). 
Therefore, the ADHD drugs are specially designed and intended 
to bind to a dopamine transporter with their nitrogen, oxygen 
or carbon atom, enabling it to transfer the dopamine to the 
brain. The nitrogen and oxygen atoms are surrounded by at 
least one lone pair which assists in the formation of a hydro-
gen bond to the dopamine transporter. However, although the 
carbon atom is lacking such a lone pair, it has interestingly been 
discovered that it too can form a bond to the dopamine carriers 
(dnalc.org).  
The question still remains, however, how do the ADHD drugs 
increase the levels of dopamine in the brain by binding to the 
dopamine transporters? There are three known mechanisms 
that ultimately inhibit the rise of dopamine in the brain. The 
dopamine rapidly diffuses into the synapse causing the dopa-
mine transporters to bind to the dopamine and positioning it 
throughout the nerve cell membrane. Then, extracellular action 
of dopamine on the auto receptors of the neuron, consequent-
ly inhibit the further release of dopamine. Thus, the dopamine 
stimulating drugs are aimed to prevent the uptake of dopamine 
by the neurons so that extracellular action will not occur. 
Furthermore, the drugs can promote additional dopamine re-
lease. For example, either the drug can bind to the dopamine 
transporters hindering it from bringing the dopamine into the 
neuron. Or, other forms of the drug can excite the release of 
more dopamine (Molecular Psychiatry, 1998). 
Additionally, the prefrontal cortex and its association with fur-
ther brain regions, such as the striatum, cerebellum are found to 
be slightly smaller or less active in ADHD victims.  Furthermore, 
the frontal lobe, basal ganglia, and the caudate nucleus, are also 
related to ADHD and they too play a significant role in regulat-
ing behavior.  Studies of animals have shown that the prefrontal 
cortex has a responsibility in regulating behavior and attention, 
as well as, understanding representational data (sciencedaily.
com). Researchers were not surprised to find a smaller pre-
frontal cortex in patients with ADHD due to the fact that the 
prefrontal cortex is critical in providing and dividing attention, 
and inhibiting distractions. Therefore, it was understood why 
the MRI’s of ADHD victims exhibited significantly smaller pre-
frontal cortexes.
Treatment of ADHD: Stimulant vs.  
Non-Stimulant Drugs
Treatments for attention deficit hyperactive disorder include 
pharmacological approaches, as well as, non-pharmacological 
care. When treated pharmacologically, the patients are cared for 
using specific prescriptions of drugs that provide them relief 
from their symptoms. Most often, stimulant drugs, drugs that 
arouse activity in the brain, are used as pharmacological treat-
ments. However, non-stimulant medications can be used as well 
(Journal of Attention Disorders, 2014).
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Psychostimulants are stimulant drugs that are psychoactive, 
meaning, they temporarily generate mental and physical func-
tions in the brain such as increased awareness and attentive-
ness (Molecular Psychiatry, 1998).   Current psychostimulants 
include D-amphetamine, D, L-amphetamine, Magnesium pemo-
line, Methylphenidate, dexmethylphenidate, mixed amphetamine 
salts and lisdexamfetamine dimesylate (LDX). Surprisingly, the 
structural composition of these molecules are all different, 
however, share a common backbone of phenyl-ethylamine with 
endogenous catecholamines, such as, norepinephrine and do-
pamine. Uptake of the psychostimulant drugs provide the brain 
with significant dopamine, thereby enabling the inhibition of 
impulses (Molecular Psychiatry, 1998).  
Methylphenidate, is an example of a short acting, central ner-
vous system, stimulant drug for children and adults. They have 
an onset of approximately 30-60 minutes and remain in action 
for about 2-5 hours. Methylphenidate regularizes certain brain 
functions, specifically in the frontal lobe, prefrontal cortex, the 
basal ganglia and cerebellum, by stimulating the brain chemicals 
dopamine and norepinephrine (Molecular Psychiatry, 1998). 
Dopamine and norepinephrine are important neurotransmitters 
in the brain, and, a lack of them can cause dysfunction in brain 
activity. Drugs that increase the dopamine or norepinephrine 
levels will, therefore, provide a short-lasting relief to individuals 
with ADHD. Methylphenidate binds to the dopamine transport-
ers, and blocks them from transporting to the neurons. In this 
way, the extracellular action in the neurons will not take place 
and further production of dopamine will not stop (L.E Arnold).
Methylphenidate also provides a therapeutic effect due to the 
slow and steady increases of the stimulants. In addition to the 
physical effect, methylphenidate also provides an emotional 
relief by increasing the child’s self-esteem and bettering their 
interactions with others.  Therefore, stimulant medications are 
usually given gradually until a beneficial, relaxing effect comes 
about (Molecular Psychiatry). Also, when treated with the sus-
tained-release preparations, they can have longer lasting effects of 
8-12 hours. Evidence to the efficacy of the drug can come from 
functional magnetic resonance imaging tests (fMRI) on ADHD pa-
tients, which have shown that after a dosage of methylphenidate, 
there was increased activations in the brain, verifying the efficacy 
of this drug. The medication has been continuously proven to 
positively affect many ADHD victims (L.E Arnold).  
Ritalin, Concerta, Quillivant XR, Daytrana, Focalin, Medikinet, 
Equasym XL and Methylin are all derivatives of methylphenidate 
and all have similar effects. Firstly, the main byproduct of meth-
ylphenidate, Ritalin, is a short-lasting drug providing immediate 
release of dopamine and norepinephrine in the body (psychcen-
tral.com). Hence, those patients in need of immediate relief will 
benefit from Ritalin. On the other hand, Concerta, is a long acting 
stimulant which increases dopamine levels gradually. Thus, one 
may not need to take more than one dose a day, due to its all-day 
symptom relief. Depending on the severity, time and frequency, 
different patience may have a preference for either the short-act-
ing Ritalin or the long lasting Concerta (healthline.com).
Furthermore, Quillivant XR may be an option to some ADHD 
patients. Quillivant XR is the only liquid long lasting medication, 
thereby, attracting young children who cannot swallow pills. In 
addition, since it is a liquid, it is easily measurable, and, there-
fore, those patients who only need a small dosage will tend to 
choose Quillivant XR. Daytrana, has an unusual advantage of ex-
isting in patch form. Meaning, a specific dosage of medication is 
located in a patch that is worn somewhere on the body usually 
the hip. Throughout the day, the Daytrana is released into the 
blood. Consequently, the effects on the patient will have a lon-
ger duration, usually lasting throughout the entire day.  Children 
typically are the most common ones to use this drug, being that 
it makes life simpler (adhd-treatment-options 2009). The next 
drug, Focalin, is also a drug that offers extended-release, and is 
found to more effective than Concerta. Focalin has proven to 
offer immediate relief first thing in the morning, and then provide 
continuous effects throughout the day, thereby allowing children 
to focus during the day in school. Therefore, Focalin has been a 
first choice drug option for school-age children (drugs.com). 
Another methylphenidate drug, Medikinet, grants immediate-re-
lief and short lasting results. Therefore, it would need to be 
taken several times a day. However, Medikinet XL is a new ver-
sion of the drug which splits up the dosage, releasing 50% im-
mediately and holding back the other 50% to be released later 
on in the day. The latter form of the drug is most probably more 
beneficial to most people, not needing to retake the medica-
tion multiple times a day (netdoctor.co.uk). Similar to Medikinet 
XL, Equasym XL, is also a pill that releases 30% immediately 
and stores the other 70% to be released hourly throughout 
the course of the day. In this case, as well, one morning capsule 
is enough to last the child the whole day. Lastly, Methylin, is 
short-lasting pills and requires multiple doses during the course 
of the day. Additionally, it has many side effects so it is not the 
best option of an ADHD drug (netdoctor.co.uk).
The second most common type of ADHD stimulant drug, 
Amphetamine, is similar to Methylphenidate, except that vari-
ants of this drug are usually intermediate-acting. For example, 
D, L-amphetamine, has a slightly longer duration of 4-6 hours. A 
blend of four amphetamine salts, amphetamine aspartate mono-
hydrate, amphetamine sulfate, dextroamphetamine sulfate and 
dextroamphetamine saccharate, produce Adderall, which is an 
equally effective drug (progressivehealth.com). Being that the 
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two main drugs are especially similar, differences between meth-
ylphenidate and amphetamine are not so distinct. However, the 
chemical activity is different. Ritalin, travels into the brain cells 
and prohibits them from continuous absorption of dopamine 
(learn.genetics). On the contrary, Adderall, not only stops the 
brain cells from absorbing the dopamine, but, also, forces the 
cells to drain the already absorbed dopamine, thereby, directly 
increasing the dopamine levels in the brain.  Furthermore, when 
methylphenidate binds to the dopamine transporters, it merely 
inhibits the uptake of dopamine by the neurons, thereby stop-
ping the inhibition of dopamine. Amphetamine furtherly differs 
from methylphenidate in that along with the immediate release 
formulation of the drug, it can provide extensive release as well. 
Therefore, less dosages per day are needed of Adderall than of 
methylphenidate. Furthermore, even though Adderall is more 
powerful than Ritalin, some people react better to Ritalin, some 
react better to Adderall and some react equally to both drugs 
(LE Arnold).  
Being that stimulant ADHD drugs are similar to cocaine and mor-
phine, many risks and side effects exist. People think that being 
that many children use it, the drug is harmless and mild. However, 
being that methylphenidate is highly addictive, many dangers are 
present. The FDA requires all Ritalin boxes to contain the fol-
lowing notification, “Ritalin is a federally controlled substance 
because it can be abused or lead to dependence. Keep Ritalin 
in a safe place to prevent misuse and abuse.” The above warning 
states that the effects Ritalin can be abused and harmful if not 
used in the correct manner. The use of this drug can also lead to 
anxiety, agitation, trouble sleeping, decreased appetite, headaches, 
stomachaches etc. More serious side effects include the chance 
for seizures, and blurred vision (ritalinsideeffects.net). The main 
concern with these stimulant drugs is its potential for physical 
and emotional abuse. Addiction to the drugs can be caused by 
increasing dosages due to a buildup of tolerance to the drugs. 
The higher dosages, may then cause the patient’s body to become 
solely dependent on the drug, craving it and eventually being un-
able to live life without it. Withdrawal from the medication can 
lead to panic attacks, depression and hunger. Therefore, limita-
tions to this drug are extremely important to prevent addiction 
and abuse (drugabuse.gov). Side effects of both medications in-
clude vomiting, nausea, anxiety, insomnia, skin rashes, headaches, 
dry mouth and agitation. Furthermore, Adderall has an additional 
side effect of increasing the risk of certain heart diseases, such 
as, heart palpitations, increased heart rates and increased blood 
pressure. 
Although stimulant medication is usually the most effective for 
treatment of ADHD, these drugs are not for everyone. Whether 
it being the intolerable side effects, or the ineffectiveness of stim-
ulants, some patients prefer the non-stimulant option remedy. 
Strattera, Clonidine, Guanfacine, Intuniv, and Kapvay, are some 
of the most popular non-stimulant possibilities.   Furthermore, 
Bupropion SR and XL, The tricyclic antidepressants, The Selective 
Serotonin Reuptake Inhibitors (SSRIs), and Effexor can also be 
used as non-stimulant relief (ncpamd.com). 
The first approved ADHD non-stimulant medication for chil-
dren and adults, Strattera, also called Atomoxetine, increases 
the amount of norepinephrine in the brain, thereby increasing 
a child’s attention span and moderating their impulsive behav-
ior (ncpamd.com). Strattera does not directly influence the 
dopamine levels as do the stimulant medications. Strattera is 
effective in decreasing the ADHD symptoms, however, it is not 
controlled and it is less likely to be abused and cause addiction. 
The clinical effects last throughout the day and therefore, more 
than one dosage a day is not necessary. Although there are some 
side effects, they are minimal and tolerable, such as, fatigue, diz-
ziness and nausea (my.clevelandclinic.org). 
Clonidine and Guanfacine, have been used in adults mainly 
to control high blood pressure but has been further used to 
control ADHD mainly in adults with impulsivity and aggression. 
Due to its painkilling and soothing characteristics, Guanfacine, 
is commonly used to help individuals fall asleep. However, due 
to the major side effects of these drugs including high blood 
pressure and heart rate, it is important to monitor one’s blood 
pressure with frequent EKG’s, electrocardiograms, tests that 
check the electrical activity of the heart.   Guanfacine lasts lon-
ger than Clonidine and only one or two dosages are needed 
per day. Furthermore, these drugs mainly relieve over activity as 
opposed to inattentiveness.     
Intuniv and Kapvay are other non-stimulating drugs approved 
by the FDA in September 2009-2010 for individuals ages 6-17. 
Both drugs can be used independently or simultaneously with 
a stimulant. They also tend to take longer than stimulants to 
show results. It may take up to a month to see their effects. 
Furthermore, just like Guanfacine and Clonidine, Kapvay may 
cause a rise in blood pressure and it therefore should be mon-
itored (ncpamd.com). 
Antidepressant drugs can also be used to cure ADHD that is 
linked to depression. Although its results are not as beneficial 
to helping children with attentiveness and remaining on task, 
children who are depressed due to their disease, commonly 
lead towards anti-depressants for help. The first, most popular, 
category of anti-depressants are The Tricyclic Antidepressants 
which include, Pamelor, Norpremine, Aventyl, and Tofranil. They 
are long-lasting so do not require frequent dosages (ncbi.nlm.
nih.gov). Tricyclics, however, can cause dry mouth, blurred vi-
sion, constipation, dizziness and sedation. Other antidepressants 
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such as Wellbutrin, Effexor, Effexor XR, and MAO inhibitors, are 
mainly used as antidepressants but can be used to treat ADHD 
by increasing serotonin in the brain, thereby, increasing concen-
tration in the child. MAO inhibitors are usually a last choice 
for ADHD patients because of their dangerous side effects 
including high blood pressure when taken with certain foods. 
Antidepressants are sometimes mixed with stimulant drugs 
when the individual is suffering from symptoms of anxiety in 
addition to their hyperactivity and inattentiveness (Journal of 
Attention Disorders, 2014). In conclusion, the use of antide-
pressants to relieve the symptoms of ADHD may be beneficial 
if monitored by a health professional. 
What is Cognitive Behavioral Therapy for 
children or adults with ADHD?
Patients diagnosed with ADHD need to manage their symptoms 
of hyperactivity, impulsivity and inability to focus their atten-
tion. CBT, cognitive behavioral therapy, consists of teaching skills 
to control these symptoms. There are two different arms to 
this strategy. One is to teach ways of staying focused and orga-
nized while the other’s goal is to minimize disruptive behaviors 
that interfere with social and academic growth. CBT is used 
both alone and in conjunction with pharmaceutical treatment 
consisting of stimulant and non-stimulant medication (Miller- 
Behavioral Treatments for Kids with ADHD). CBT is important 
as, unlike medication, it teaches life skills that can serve the pa-
tient even after medication is stopped.
For children with behavior problems that detracts from their 
academic progress and causes conflict both at home and in 
school, parent-child interaction therapy, PCIT, may be beneficial. 
It involves 14-17 week sessions in which parent-child interaction 
is viewed through a one way mirror and the parent is coached 
by a phycologist using an ear bud. Parents are encouraged to use 
positive reinforcement in conjunction with strict consequences 
for inappropriate behaviors. These techniques are meant to be 
continued at home and in school. Teacher involvement is en-
couraged and essential.  Goals are set, such as following specific 
classroom rules with a prize following each positive behavior. 
Over time, he child learns to control behavior and therefore, 
have more beneficial interactions with parents, teachers, and 
peers (Miller, Child Mind Institute). 
Another form of behavior therapy involves the attention aspect 
of the disorder. These include techniques to establish routines 
to allow the ADHD patient to organize himself, allowing him to 
stay on task and accomplish his goals. It also focuses on transi-
tioning techniques to allow for less distraction. Everyday tasks 
such as homework or bed time are broken down into smaller 
achievable steps (Miller, Child Mind Institute). In general, both 
methods of CBT have been shown to be more effective the 
younger the child is, and less benefit has been seen by those 
children who have reached adolescence. 
Cognitive Behavioral Therapy as a viable 
treatment for ADHD
Because the use of pharmacological treatments of ADHD may 
not be acceptable to some parents of affected children or the 
affected individuals themselves, cognitive behavioral therapy, 
CBT, has been an alternative to the use of these medications. 
CBT has long been used to treat ADHD both in conjunction 
with medication or on its own. However, not many studies are 
available comparing CBT applied on its own, to medication 
alone, to a combination of CBT and pharmaceutical options 
(Journal of Attention Disorders, 2014). A study by Susan Young 
and J. Myanthi Amarasinghe view these possible treatment op-
tions through the lifespan of the ADHD patient uncovering ev-
idence which suggests different approaches to treatment are 
more effective during different periods in the patient’s life. 
The young preschool child, who is still cognitively immature, 
cannot yet put into practice skills that are taught directly. He 
responds best to parental training to enforce positive behav-
ior control such as tangible consequences along with positive 
support to reinforce good behavior. It has been noted that 
preschoolers that do not meet criteria for diagnosis and there-
fore do not receive early treatment were further affected into 
their school years and beyond than those children treated early 
(Young and Amarasinghe). In addition, parent-child relationships 
are strained during these early years creating stress that lingers 
into adulthood. Because the focus of a child’s life at this time 
is his home and parents, parent training is the most effective 
treatment yielding the most benefits throughout the patient’s 
lifetime. Parenting techniques and interventions include teaching 
parents about ADHD and addressing and targeting behavioral 
problems associated with it. Reward and positive reinforce-
ments for appropriate social behaviors are stressed in conjunc-
tion with consequences for negative and socially inappropriate 
behaviors. Parents may also be offered support groups to deal 
with their own reactions to their child’s difficulties (Young and 
Amarasinghe). 
Older, school age children, are cognitively capable of learning 
skills and techniques to aid in social and academic situations. 
They appreciate being involved in their care at this stage in their 
development. This type of behavior therapy can be developed to 
aid in treatment of older adolescence as well as adult patients. 
These patients exist in two basic environments: at home and at 
school, therefore treatment must be tailored to these situations. 
Home-school connections must be fostered and communica-
tion between the two is imperative. Parent training is similar to 
that of younger children as described above while teachers are 
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coached to set achievable academic and social goals in addition 
to positive reinforcement along with tangible consequences for 
behavioral issues or impulsivity (Miller, Child Mind Institute). 
As children move past their elementary school year, a child is 
able to be more involved in his behavioral therapy. He is able to 
be involved in role playing to advance social skills and improve 
communication with eye contact and body language. An adoles-
cent can be taught how to give compliments, accept construc-
tive criticism, take turns and resolve conflicts. He can be taught 
to actively listen to and follow directions and monitor his own 
attention All of these will improve the patient’s relationships and 
academic achievement improving self-esteem. As an adolescent 
enters adulthood, all of these techniques can be furthered, set-
ting direct treatment goals such as dealing with procrastination 
and developing strategies to aid in memory and impulsivity con-
trol (Miller, Child Mind Institute). 
There are ongoing discussions in the medical and psychiatric 
communities on which avenues of treatment to choose as the 
optimal way to treat ADHD. Depending on the age of the child, 
the first line of defense may be different. The ADHD NICE 
Clinical Guideline advises that parent training be the initial 
treatment in preschool children and young school age children 
with behavioral issues.  Parent training is not as effective in older 
children. Parent training has also been shown to be less effec-
tive in cases where the parents themselves exhibit symptoms of 
ADHD (Young and Amarasinghe). 
In a Multimodal Treatment study, four treatment possibilities 
were compared. Firstly, medication, in the form of methylpheni-
date. Second, CBT including parent training, summer treatment 
programs and school based treatment. Third, A combined treat-
ment including medication and behavior therapy. And, lastly, a 
control group of community care consisting of children, many of 
whom were medicated, but did not receive treatment from the 
researchers. Results found that the medication and combined 
tracks were more effective than behavioral therapy alone or 
the community care.  The combined treatment which consisted 
of medication and CBT in combination was more effective for 
symptoms reported by parents then medication alone. In ad-
dition, CBT, with or without medication was very effective for 
those patients from poorer socioeconomic groups who were 
receiving public assistance. The combination treatment was 
more effective and less costly for patients with many comor-
bid symptoms. In addition, it is important to note that children 
in the combination treatment were able to control symptoms 
with lower doses of medication (JAMA Psychiatry). 
As patients enter adolescence, boys and girls may present with 
different symptoms and, therefore, may need different courses 
of treatment. Boys have a tendency to be more aggressive and 
the need for behavior control is more pressing while girls may 
have more social and emotional symptoms requiring social and 
mood altering treatments. It is for this reason that at this stage, 
teens must be made an integral part of their own treatments. 
Parent training at this stage includes the same basic premise 
as younger children with positive reinforcements becoming 
more age appropriate. For example, positive reinforcement in-
cludes more time with friends or more computer time while 
consequences for negative behavior may be losing privileges 
(Miller, Child Mind Institute). Working closely with teachers 
and counselors at this stage is most important as difficulties 
in school is a major concern. It seems that CBT and parent 
training alone is not as effective in the adolescent group as in 
younger children and a combined regimen including medication 
and behavior intervention is more effective than either alone 
(JAMA Psychiatry). More studies on adolescents need to be un-
dertaken, however, since most assume that their problems may 
be successfully addressed using similar methods as those used 
for their younger counterparts.
Conclusion
ADHD is a developmental and neuropsychological disease 
caused by low levels of dopamine release that presents with 
symptoms including behavioral impulsivity and inability to focus, 
along with the possibility of comorbid conditions of depression 
and behavioral defiance. It is a disease which may present at any 
time throughout a lifespan, but treatment is most effective when 
diagnosed and treated earlier in life. There are many treatment 
options available to the ADHD patient including stimulant and 
non-stimulant medications which may be administered in many 
modalities and doses to fit many different lifestyles. Non phar-
macological approaches include cognitive behavior therapies, 
including parent and teacher training, student workshops and 
summer training programs. Individualized approaches to treat-
ments seem to be the most effective based on a patient’s age, 
symptoms, socio-economic group, and sex. In general, combined 
medication therapy with different forms of CBT tailored to pa-
tient lifestyle as he grows is the most effective treatment. 
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